市場調査レポート

世界の麻酔薬市場(全身麻酔・局所麻酔・補助療法)

The World Anesthesia Drug Market (General, Local, Adjunctive)

発行 Kalorama Information 商品コード 235125
出版日 ページ情報 英文 152 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.18円で換算しております。
Back to Top
世界の麻酔薬市場(全身麻酔・局所麻酔・補助療法) The World Anesthesia Drug Market (General, Local, Adjunctive)
出版日: 2012年03月22日 ページ情報: 英文 152 Pages
概要

当レポートでは、世界の麻酔薬市場における3つの主要セグメント - 全身麻酔・局所麻酔・補助療法 - について調査し、セグメント別の上市製品、製品開発、市場規模と予測、主要企業の市場シェア、および課題と動向を分析しており、概略以下の内容でお届けいたします。

第1章 エグゼクティブサマリー

第2章 イントロダクション

  • 麻酔薬のイントロダクション・歴史
  • 投与経路
  • 流通チャネル
  • 人口動態・統計
  • 医療処置数:種類別
  • 麻酔の合併症
  • 麻酔学:労働力

第3章 全身麻酔

  • 概要
  • 全身麻酔の段階
  • 手術麻酔
  • 過剰摂取
  • 製品説明
  • ジェネリック医薬品の影響とアベイラビリティ
  • 研究開発
  • 市場規模・成長率
  • 競合分析

第4章 局所麻酔

  • 概要
  • 投与技術
  • 製品説明
  • ジェネリック医薬品の影響とアベイラビリティ
  • 研究開発
  • 市場規模・成長率
  • 競合分析

第5章 補助療法

  • 概要
  • 製品説明
  • ジェネリック医薬品の影響とアベイラビリティ
  • 研究開発
  • 市場規模・成長率
  • 全体市場
  • 地域別市場
  • 競合分析

第6章 総市場規模・予測

  • 総市場規模・予測
  • コンペティター分析

第7章 問題・動向

  • イントロダクション
  • 麻酔薬の規制
  • 歯科と麻酔薬
  • 小児への麻酔薬使用と合併症
  • 麻酔薬のアレルギー反応
  • プロポフォールのリコール
  • 麻酔薬とうつ病患者へのメリット
  • 双極性障害における小児への研究
  • 麻酔薬と睡眠
  • 麻酔反応の性別差異
  • 製造・供給の問題
  • 医薬品の不足
  • プロポフォール
  • 娯楽目的での麻酔薬の使用
  • 意識化鎮静の動向
  • 麻酔薬の長期的影響
  • 麻酔薬と麻痺技術
  • SEDASYS システム

第8章 企業プロファイル

  • イントロダクション
  • 買収・同盟・協定
  • Hospira と DURECT Corporation
  • Hospira とJavelin Pharmaceuticals, Inc.
  • ZARS Pharma と Nuvo Research, Inc.
  • Abbott Laboratories
  • AstraZeneca
  • Baxter International
  • Eisai Co., Ltd.
  • Endo Pharmaceuticals, Inc.
  • Hospira, Inc.
  • Merck/Schering-Plough
  • Roche

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: KLI6859394

Abstract

This Kalorama Information report - The World Anesthesia Drug Market - focuses on three primary segments of anesthesia:

  • General Anesthesia
  • Local Anesthesia
  • Adjunctive Therapies in Anesthesia

The report covers both currently marketed and late stage development anesthesia drugs. For each of these segments the report contains:

  • Products on the Market
  • Products in Development
  • Market Size and Forecast
  • Market Share of Key Players
  • Issues and Trends

Revenues for each segment were generated using dollar and unit sales for each product. Forecasted figures were generated using a combination of projected surgical procedures, patent and exclusivity expirations, pricing trends, new developments and other factors.

The report includes statistical information for surgical procedures, incidence of conditions requiring surgery, and other relevant information. Statistical information is presented as a worldwide overview, with special emphasis on the U.S. Product chapters in this report provide an overview, description of products on the market, description of products in development, market estimates and forecasts, and competitive analysis of leading providers. The report also includes current issues and trends affecting the industry.

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study Kalorama Information conducted interviews with more than 50 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with pharmaceutical company representatives included marketing directors, division managers, and product representatives.

There are several issues and trends that are impacting the anesthesia drug market. Many of the issues are centered on safety issues, which are probably one of the most important aspects of the administration of anesthetic agents. This industry is a mature industry so it does not have the typical competitive issues often seen in other pharmaceutical segments. However, there are some issues that concern research and development of promising areas in anesthesia.

Topics included in this section include:

  • Introduction
  • Regulation of Anesthesia Drugs
  • Dentistry and Anesthesia
  • Anesthesia and Complications in Pediatric Applications
  • Allergic Reactions in Anesthesia ( inc. Propofol Recall)
  • Anesthesia and the Benefits to Depression Patients
  • Pediatric Studies in Bipolar Disorders
  • Anesthesia and Sleep
  • Gender Differences in Anesthesia Reaction
  • Manufacturing and Supply Issues
  • Drug Shortages
  • Recreational Use of Anesthetics
  • Trends in Conscious Sedation
  • Long-term Effects of Anesthesia
  • Anesthesia and Numbing Technologies

Several hundred companies compete worldwide in the anesthesia drug market. Companies in the market consist of large pharmaceutical companies, niche pain management and anesthesia drug manufacturers, and worldwide generic drug providers.

All market data pertains to the world market at the manufacturers' level. The base year for data was 2011. Historical data was provided for the years 2007 through 2010, with forecast data provided for 2012 through 2016. Compound annual growth rates (CAGRs) are provided for the 2007-2011, 2007-2016 and 2012-2016 periods for each industry segment covered. Competitive analysis is provided for the years 2009-2011. The forecasted market analysis for 2012-2016 was highly influenced by the probability of approval and sales of products in late stage development, product marketing, generic competition, and demographic trends.

Table of Contents

ONE: EXECUTIVE SUMMARY

  • Introduction
  • Scope and Methodology
  • Size and Growth of the Market
  • Issues and Trends Affecting Market
  • Leading Competitors

TWO: INTRODUCTION

  • Introduction and History to Anesthesia Drugs
  • Types of Anesthesia
    • General Anesthesia
    • Local Anesthesia
    • Adjunctive Therapies in Anesthesia
  • Routes of Administration
    • Inhalation
    • Mask Inhalation
    • Laryngeal Mask
    • Endotracheal Administration
    • Controlled Respiration
    • Intravenous
    • Topical Application
    • Transdermal/Transmucosal Application
  • Distribution Channels
  • Demographics and Statistics
  • Medical Procedures by Type
  • Complications in Anesthesia
  • Anesthesiology - Work Force

THREE: GENERAL ANESTHESIA

  • Overview
  • Stages of General Anesthesia
    • Induction
    • Excitement
  • Surgical Anesthesia
  • Overdose
  • Description of Products
    • Brevital
    • Diprivan
    • Ethrane
    • Forane
    • Halothane
    • Ketalar
    • Lusedra
    • Pentothal
    • Suprane
    • Ultane/Sevorane
  • Generic Drug Impact and Availability
  • Research and Development
  • Market Size and Growth
    • Total Market
    • Market by Delivery Method
    • Market by Geographical Region
  • Competitive Analysis

FOUR: LOCAL ANESTHESIA

  • Overview
  • Techniques of Administration
    • Topical Application
    • Transdermal/Transmucosal
    • Simple Local Infiltration
    • Regional Injections
    • Spinal and Epidural Anesthesia
    • Intrathecal Block
    • Epidural, Peridural Block
  • Description of Products
    • Amides
    • Carbocaine/Isocaine/Polocaine
    • Citanest
    • Exparel
    • Marcaine/Sensorcaine
    • Naropin
    • Septocaine
    • Xylocaine/LidoSite/Lidoderm
    • Esters
    • Cocaine Hydrochloride
    • Nesacaine
    • Novocaine
    • Pontocaine
    • Combinations
    • EMLA
    • Pliaglis
    • Synera
  • Generic Drug Impact and Availability
  • Research and Development
  • Market Size and Growth
    • Total Market
    • Market by Delivery Method
    • Market by Geographical Region
  • Competitive Analysis

FIVE: ADJUNCTIVE THERAPIES

  • Overview
  • Description of Products
    • Neuromuscular Blocking Agents
    • Preanesthetic Sedation and Anesthesia Maintenance
    • Precedex/dexdor
    • Anesthesia Reversal Agents
  • Generic Drug Impact and Availability
  • Research and Development
    • Bridion (sugammadex)
    • Gantacurium
    • Remimazolam (CNS 7056)
  • Market Size and Growth
  • Total Market
  • Market by Geographical Region
  • Competitive Analysis

SIX: TOTAL MARKET SIZE AND FORECAST

  • Total Market Size and Forecast
    • Anesthesia Market by Product Type
    • Anesthesia Market by Geographical Region
  • Competitor Analysis

SEVEN: ISSUES AND TRENDS

  • Introduction
  • Regulation of Anesthesia Drugs
  • Dentistry and Anesthesia
  • Anesthesia and Complications in Pediatric Applications
  • Allergic Reactions in Anesthesia
  • Propofol Recall
  • Anesthesia and the Benefits to Depression Patients
  • Pediatric Studies in Bipolar Disorders
  • Anesthesia and Sleep
  • Gender Differences in Anesthesia Reaction
  • Manufacturing and Supply Issues
  • Drug Shortages
  • Propofol
  • Recreational Use of Anesthetics
  • Trends in Conscious Sedation
  • Long-term Effects of Anesthesia
  • Anesthesia and Numbing Technologies
  • Sedasys

EIGHT: CORPORATE PROFILES

  • Introduction
  • Acquisitions, Alliances and Agreements
  • Hospira and DURECT Corporation
  • Hospira and Javelin Pharmaceuticals, Inc.
  • ZARS Pharma and Nuvo Research, Inc.
  • Abbott Laboratories
  • AstraZeneca
  • Baxter International
  • Eisai Co., Ltd.
  • Endo Pharmaceuticals, Inc.
  • Hospira, Inc.
  • Merck/Schering-Plough
  • Roche

APPENDIX: List of Companies

LIST OF TABLES

ONE: EXECUTIVE SUMMARY

  • Table 1-1: The Total World Market for Anesthesia Drugs 2007-2016
  • Figure 1-1: The Total Market for Anesthesia Drugs 2007-2016

TWO: INTRODUCTION

  • Table 2-1: World Population by Selected Geographical Region, 2010 - 2050
  • Figure 2-1: World Population by Selected Geographical Region, 2010 - 2050
  • Table 2-2: Procedures by Type, Average Annually 2007-2011
  • Figure 2-2: Procedures by Type Worldwide, Average Annually 2007-2011
  • Figure 2-3: Procedures by Type U.S., Average Annually 2007-2011
  • Table 2-3: Worldwide Anesthesia Complications
  • Table 2-4: U.S. Physician Work Force (including Anesthesiologists) by Year
  • Figure 2-4: U.S. Physician Work Force (including Anesthesiologists) by Year

THREE: GENERAL ANESTHESIA

  • Table 3-1: Marketed Brands for General Anesthesia Drugs
  • (Brand Name, Generic Name, and Supplier)
  • Table 3-2: Selected Generic Drug Manufacturers and Products for General Anesthesia
  • Table 3-3: Brand vs. Generic General Anesthetic Market 2007-2011
  • Table 3-4: The Market for General Anesthesia Drugs 2007-2016
  • Figure 3-1: The Market for General Anesthesia Drugs 2007-2016
  • Figure 3-2: The Market for General Anesthesia Drugs Market Share by Delivery Method, 2011
  • Table 3-5: The Market for General Anesthesia Drugs Estimated Products Sales by Geographic Region, 2011
  • Figure 3-3: The Market for General Anesthesia Drugs Market Share by Geographic Region, 2011
  • Table 3-6: The Market for General Anesthesia Drugs Estimated Revenues and Market Share of Leading Suppliers 2009-2011
  • Figure 3-4: The Market for General Anesthesia Drugs Estimated Market Share by Leading Suppliers 2011

FOUR: LOCAL ANESTHESIA

  • Table 4-1: Selected Marketed Local Anesthesia Drugs (Brand Name, Generic Name and Supplier)
  • Table 4-2: Selected Generic Drug Manufacturers and Products for Local Anesthesia
  • Figure 4-1: Brand vs. Generic Local Anesthetic Market 2007-2011
  • Table 4-3: Local Anesthesia Drugs in Development
  • Table 4-4: The Market for Local Anesthesia Drugs 2007-2016
  • Figure 4-2: The Total Market for Local Anesthesia Drugs 2007-2016
  • Figure 4-3: The Market for Local Anesthesia Drugs Market Share by Delivery Method, 2011
  • Table 4-5: The Market for Local Anesthesia Drugs Estimated Products Sales by Geographic Region, 2011
  • Figure 4-4: The Market for Local Anesthesia Drugs Market Share by Geographic Region, 2011
  • Table 4-6: The Market for Local Anesthesia Drugs Estimated Revenues and Market Share of Leading Suppliers 2009-2011

Figure 4-5: The Market for Local Anesthesia Drugs Estimated Market Share by Leading Suppliers 2011

FIVE: ADJUNCTIVE THERAPIES

  • Table 5-1: Selected Marketed Adjunctive Therapies in Anesthesia (Type, Brand Name, Generic Name, and Supplier)
  • Table 5-2: Selected Generic Drug Manufacturers and Products for Adjunctive Therapies in Anesthesia
  • Figure 5-1: Brand vs. Generic Adjunctive Therapies in Anesthesia Market 2007-2011
  • Table 5-3: Adjunctive Therapies in Anesthesia in Development
  • Table 5-4: The Market for Adjunctive Therapies in Anesthesia 2007-2016
  • Figure 5-2: The Market for Adjunctive Therapies in Anesthesia 2007-2016
  • Table 5-5: The Market for Adjunctive Therapies in Anesthesia Estimated Products Sales by Geographic Region, 2011
  • Figure 5-3: The Market for Adjunctive Therapies in Anesthesia Market Share by Geographic Region, 2011
  • Table 5-6: The Market for Adjunctive Therapies in Anesthesia Estimated Revenues and Market Share of Leading Suppliers 2009-2011
  • Figure 5-4: The Market for Adjunctive Therapies in Anesthesia Estimated Market Share by Leading Suppliers 2011

SIX: TOTAL MARKET AND FORECAST

  • Table 6-1: The Total World Market for Anesthesia Drugs 2007-2016
  • Figure 6-1: The Total Market for Anesthesia Drugs 2007-2016
  • Table 6-2: Anesthesia Drug Market by Type 2007-2016
  • Figure 6-2: Anesthesia Drug Market by Type 2007-2016
  • Figure 6-3: Anesthesia Drug Market by Type 2011
  • Figure 6-4: Anesthesia Drug Market by Type 2016
  • Table 6-3: Anesthesia Drug Market Estimated Products Sales by Geographic Region, 2011
  • Figure 6-5: Anesthesia Drug Market Market Share by Geographic Region, 2011
  • Table 6-4: Leading Suppliers Anesthesia Revenues and Significant Segments of Participation, 2011
  • Figure 6-6: Leading Suppliers - Anesthesia Revenues, 2011
Back to Top